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Synthesis of Cisplatin & biological testing of the complex, compared to Triplatin (BBR3464)
Heba Dawood, Dr. Nicholas Farrell

Abstract
Two chemotherapeutic drugs were studied; one of them is
Cisplatin that is currently used to fight cancer and the other is
Triplatin (BBR3464) that was developed by Dr. Farrell. Cisplatin
was synthesized and many different experiments were conducted
such as: Recrystallization, Infrared Spectroscopy, UV-VIS, Melting
Point, and Fluorescence experiment. After synthesizing the drug, it
was tested in biology lab; we tested the effects of the drug on
ovary cancer cells and its ability to kill cancer cells. A Cisplatin
MTT ASSAY experiment was done and another MTT for Triplatin
was done. Results from both of the experiments were compared
and it was concluded that Triplatin is able to kill cancer cells more
effectively and at lower concentrations than Cisplatin.

Conclusion

Results/Discussion
Cisplatin-IC50=1.77μM
Triplatin (BBR3464)-IC50=0.76µM
These results show that it takes less amount of Triplatin to kill
cancer cells than Cisplatin; we only need 0.76µM of Triplatin to
kill about 50% of the cancer cells

Cisplatin is a good chemotherapeutic drug but it has side effects
and therefore Dr. Farrell developed a new chemotherapeutic drug
that is Triplatin. Also, Killing cancer cells using Triplatin requires
only a small amount of it compared to Cisplatin

Control
50%

Control
50%

25%

25%

12.5%
6.25%

12.5%
6.25%

3.125%
1.56%

3.125%
1.56%

Introduction
Cisplatin is an anti-cancer drug that is currently being used to
treat cancer patients. It binds to DNA, bends it and changes the
shape of it. However, it has some side effects such as
Nephrotoxicity. Therefore, there is a need to develop other drugs
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Comparison on the amount needed to kill specific % of cancer cells
between Triplatin (Left) and Cisplatin (Right)
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Many experiments were conducted:
For Cisplatin: Synthesis, Filteration, Elemental Analysis, Infrared,
Spectroscopy (IR), UV-VIS, Melting Point and Fluorescence
Experiment)
Then, biological testing for Cisplatin and Triplatin; (Cisplatin
MTT ASSAY experiment MTT ASSAY for Triplatin)
Methods for MTT ASSAY:
•1st day: change cell’s media, count cells, do the calculations,
incubate cells for 24 hours
•2nd day: prepare the drug samples, give them to cells, incubate for
72 hours
•Lastly; give the cells the MTT compound, wait 3 hours, then
solubilization solution.
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